a Johnson Matthey Company, has published a new "Discovery to Market"
Pharmaceutical Services brochure that outlines services from Lab to Bulk API
production provided by Alfa Aesar and Johnson Matthey Pharmaceutical Services.
The eight-page brochure details the chemical products and services offered
by Alfa Aesar and Johnson Matthey Pharmaceutical Services to cover the full
scope of the drug development pipeline. The pharmaceutical portfolio includes
a catalog of over 30,000 building blocks and screening compounds, cGMP compliant
commercial manufacturing and a full suite of services in between. Alfa Aesar
and Johnson Matthey Pharmaceutical Services offer full regulatory and cGMP compliance
in all aspects, including chemical development, catalytic screening, lab scale
production and more.
To request a free copy of the Discovery to Market Pharmaceutical Services brochure,
contact Alfa Aesar at 1-800-343-0660 or email email@example.com.